Gastroentero s.r.o.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis2 trials

Phase

• Phase 22 trials

Status

• Recruiting2 trials

Lead sponsor

• Eli Lilly & Co.1 trial
• Eli Lilly and Company1 trial

Running trials

• Recruiting

  A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)

  2025-524404-29-00· Phase 2· Eli Lilly & Co.· Source

• Recruiting

  LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  NCT07415044· Phase 2· Eli Lilly and Company· Source

  Contact: Vladimir Klinovsky (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ulcerative colitis2 recruiting